President Donald Trump announced agreement on Most Favored Nations (MFN) drug pricing deals with Eli Lilly & Company and Novo Nordisk, marking the fourth and fifth major drug companies with which the administration has reached deals in recent months.
When purchased through the forthcoming TrumpRX website, which will be operational in January, the Novo Nordisk-
Continue Reading on Breitbart
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.